Chenghui Huang

Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial

Di Wu, Jing Li, Dong Xu et al. · Annals of the Rheumatic Diseases · 2023 · 140 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +8

Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial

Dong Xu, Jianmin Fang, Shangzhu Zhang et al. · Lara D. Veeken · 2023 · 72 citations

Medicine, Pharmacology, Pharmacotherapy +15

The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI

Ni He, Haoqiang He, Kui‐Yuan Liu et al. · Cancer Imaging · 2020 · 67 citations · Full text

Medicine, Oncology, Radiology +17

Clinicopathologic Evaluation of Prognostic Factors for Squamous Cell Carcinoma of the Buccal Mucosa

Chenghui Huang, Sau‐Tung Chu, Luo‐Ping Ger et al. · Journal of the Chinese Medical Association · 2007 · 64 citations

Medicine, Oncology, Surgery +17

Lnc-DC regulates cellular turnover and the HBV-induced immune response by TLR9/STAT3 signaling in dendritic cells

Lifan Zhuang, Jianhua Tian, Xinzhi Zhang et al. · Cellular & Molecular Biology Letters · 2018 · 51 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17